piracetam has been researched along with Atherogenesis in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DW | 1 |
| Lee, SY | 1 |
| Shon, YM | 1 |
| Kim, JH | 1 |
| Stroganova, IM | 1 |
| Kiparisov, MA | 1 |
2 other studies available for piracetam and Atherogenesis
| Article | Year |
|---|---|
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Biomarkers; Carbamaz | 2013 |
[Omaron in the restorative treatment of patients with chronic cerebrovascular insufficiency].
Topics: Administration, Oral; Atherosclerosis; Brain Ischemia; Calcium Channel Blockers; Carotid Arteries; C | 2010 |